Company Filing History:
Years Active: 2013
Title: **Daniel Robert Rubio: Innovator in Antibody Development**
Introduction
Daniel Robert Rubio, an accomplished inventor based in Doylestown, Pennsylvania, has made significant contributions to the field of biochemistry. With a focus on developing antibodies for beta-N-methylamino-L-alanine (BMAA), his work has implications for both research and medical applications.
Latest Patents
Daniel holds one patent, which pertains to "Antibodies and assays for beta-N-methylamino-L-alanine." This patent details the production and use of antibodies against BMAA, alongside related kits, immunogens, and methods utilized to obtain these antibodies. This innovation provides a vital tool for researchers studying the biochemical interactions and effects of BMAA.
Career Highlights
Currently, Daniel is employed at Abraxis, Inc., a company known for its commitment to innovative solutions in the field of biotechnology. His work at Abraxis allows him to collaborate with other talented professionals, advancing the frontiers of research in antibody development.
Collaborations
One of Daniel's notable collaborators is Fernando Manuel Rubio. Their combined expertise enhances their projects and drives forward the innovation landscape at Abraxis, further solidifying their impact on the field.
Conclusion
Daniel Robert Rubio is a prominent figure in biochemistry, with his innovative work on antibodies against BMAA marking a significant step forward. His contributions not only advance scientific understanding but also pave the way for future research endeavors that could lead to new therapeutic solutions.